Proteasome inhibition in cancer: Development of PS-341
References (42)
- et al.
Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids
Bioorg Med Chem Lett
(1998) - et al.
p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
Cell
(1994) - et al.
Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of iκb-α
J Biol Chem
(1996) - et al.
Role of IκBα ubiquitination in signal-induced activation of NFκB in vivo
J Biol Chem
(1996) - et al.
NF-κB and chemoresistance: Potentiation of cancer chemotherapy via inhibition of NF-κB
Drug Resist Updates
(1999) - et al.
Enhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κB
Int J Radiat Oncol Biol Phys
(2001) - et al.
Proteasome inhibitors: A novel class of potent and effective antitumor agents
Cancer Res
(1999) - Bold R, Virudachalam S, McConkey D: Chemosensitization of pancreatic cancer by inhibition of the 26S proteasome. J Surg...
- et al.
Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: Implications for systemic nuclear factor-κb inhibition
Cancer Res
(2001) - et al.
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells
Cancer Res
(2001)
26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer
J Cell Biochem
(2001)
Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-κb, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma
Clin Cancer Res
(2001)
The SCFβ-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in iκbα and β-catenin and stimulates IκBα ubiquitination in vitro
Genes Dev
(1999)
A phase I trial of the novel proteasome inhibitor PS-341 in advanced solid tumor malignancies
Dose dependent inhibition of 20S proteasome results in serum Il-6 and PSA decline in patients (PTS) with androgen-independent prostate cancer (AI PCa) treated with the proteasome inhibitor PS-341
Structure of 20S proteasome from yeast at 2.4 Å resolution
Nature
(1997)
Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution
Science
(1995)
Catalytic mechanism of the 20S proteasome of Thermoplasma acidophilum revealed by x-ray crystallography
Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts
Cell Death Differ
(1998)
Increased sensitivity of CLL-derived lymphocytes to apoptotic death activation by the proteasome-specific inhibitor lactacystin
Br J Haematol
(1999)
Protease inhibitor-induced apoptosis: Accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition
Leukemia
(1999)
Cited by (215)
Ubiquitin, Ubiquitin-Like Proteins, and Proteasome-Mediated Degradation
2022, Encyclopedia of Cell Biology: Volume 1-6, Second EditionThe Holy Grail: Solid Tumor Efficacy by Proteasome Inhibition
2017, Cell Chemical BiologyBortezomib Increased Vascular Permeability by Decreasing Cell–Cell Junction Molecules in Human Pulmonary Microvascular Endothelial Cells
2023, International Journal of Molecular Sciences
Copyright © 2001 Published by Elsevier Inc.